Jennifer Tousignant
General Counsel bei VIRIDIAN THERAPEUTICS, INC.
Aktive Positionen von Jennifer Tousignant
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
VIRIDIAN THERAPEUTICS, INC. | General Counsel | 15.02.2024 | - |
Karriereverlauf von Jennifer Tousignant
Ehemalige bekannte Positionen von Jennifer Tousignant
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
XILIO THERAPEUTICS, INC. | General Counsel | 01.01.2020 | 01.11.2020 |
TESARO INC | General Counsel | 01.04.2016 | 01.10.2019 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - | - |
SANA BIOTECHNOLOGY, INC. | General Counsel | 01.09.2022 | - |
Ausbildung von Jennifer Tousignant
Suffolk University Law School | Graduate Degree |
University of Virginia | Undergraduate Degree |
Statistik
International
Vereinigte Staaten | 8 |
Operativ
General Counsel | 4 |
Graduate Degree | 1 |
Undergraduate Degree | 1 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 3 |
---|---|
VIRIDIAN THERAPEUTICS, INC. | Health Technology |
SANA BIOTECHNOLOGY, INC. | Health Technology |
XILIO THERAPEUTICS, INC. | Health Technology |
Private Unternehmen | 2 |
---|---|
Tesaro, Inc.
Tesaro, Inc. Pharmaceuticals: MajorHealth Technology TESARO, Inc. is an oncology-focused biopharmaceutical company, which engages in the research and development of biopharmaceutical products. The firm offers Niraparib products. The company was founded by Leon Oliver Moulder, Jr., Mary Lynne Hedley, and Richard J. Rodgers on March 26, 2010 and is headquartered in Waltham, MA. | Health Technology |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
- Börse
- Insiders
- Jennifer Tousignant
- Erfahrung